NDC 51079-723-01 - Oxybutynin Chloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51079-723
Requested NDC
51079-723-01
Package NDCs from labels
51079-723-01, 51079-723-20
Manufacturer
Mylan Institutional Inc.
Effective date
2019-12-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Oxybutynin Chloride - Mylan Institutional Inc.Mylan Institutional Inc.2019-12-30HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-723-01EA - Each51079-723729960c5-4f69-4ac6-8283-7cb727a2d31412012-07-24
51079-723-20EA - Each51079-723486fab7e-6612-481e-98fb-ce7043b6a38312012-07-24
51079-723-63EA - Each51079-72310592e4a-2e4f-40db-abff-b9ee69c891f012012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OXYBUTYNIN CHLORIDEACTIVE INGREDIENTL9F3D9RENQOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
OXYBUTYNINACTIVE MOIETYK9P6MC7092OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AINACTIVE INGREDIENTNX76LV5T8JOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IEOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
POVIDONESINACTIVE INGREDIENTFZ989GH94EOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
TALCINACTIVE INGREDIENT7SEV7J4R1UOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
TRIACETININACTIVE INGREDIENTXHX3C3X673OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMOXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 147 · 2,924 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eyewash Station Additive ConcentrateCHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOLEncon Safety Products, Inc.b5a62567-c9f1-0492-e053-2a95a90ab2472026-11-05WarningsExact identifier
unii: 6DC9Q167V3
OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEPD-Rx Pharmaceuticals, Inc.3a319017-4e25-402e-8ba0-63b9f1eb707e2026-11-04Warnings, Adverse reactionsExact identifier
unii: L9F3D9RENQ
COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50TITANIUM DIOXIDE, ZINC OXIDECOOLA, LLCcb95c712-1680-4040-e053-2995a90af0042026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38TITANIUM DIOXIDEEai-jr 286, Inc303d5d5a-4c7a-1e23-e063-6294a90a0e582026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta BeigeTITANIUM DIOXIDEEAI-JR 286, Inc.b9ea12e8-6ed9-d805-e053-2a95a90aa1072026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra Pearl White Face Stick SPF 50PADIMATE O, TITANIUM DIOXIDEEai-jr 286, Incb69a75e0-8724-35ae-e053-2a95a90a5f342026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Vertra S Dorian Kona Gold Signature Face Stick SPF 38TITANIUM DIOXIDEEai-jr 286, Incb6c316c3-661b-6428-e053-2a95a90a1a6b2026-11-04WarningsExact identifier
unii: 15FIX9V2JP
Oxybutynin Chloride Extended ReleaseOXYBUTYNIN CHLORIDEPD-Rx Pharmaceuticals, Inc.e466d963-469a-4b1c-87f9-2e3e1e9bdf3d2026-11-02Warnings, Adverse reactionsExact identifier
unii: L9F3D9RENQ
OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEPD-Rx Pharmaceuticals, Inc.8bd5dce0-d56a-4e64-8de7-e7cd7775526b2026-11-02Warnings, Adverse reactionsExact identifier
unii: L9F3D9RENQ
HERA SILKYSTAY FOUNDATION 34W1TITANIUM DIOXIDEAmorepacific Corporation5f3ef340-c68e-1790-e063-6394a90a44aa2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35C1TITANIUM DIOXIDEAmorepacific Corporation5f40c97f-b90e-bec7-e063-6394a90ae5db2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 35N1TITANIUM DIOXIDEAmorepacific Corporation5f40f46b-c6b2-df1f-e063-6394a90afd962026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 37W1TITANIUM DIOXIDEAmorepacific Corporation5f4105f3-d08b-edb5-e063-6394a90ad28b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 39N1TITANIUM DIOXIDEAmorepacific Corporation5f41120a-521a-f5ac-e063-6394a90ac0212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 41W1TITANIUM DIOXIDEAmorepacific Corporation5f4158f0-c743-29c2-e063-6394a90ac7212026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43N1TITANIUM DIOXIDEAmorepacific Corporation5f41ecb2-9fe5-ade7-e063-6294a90abc4e2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 43O1TITANIUM DIOXIDEAmorepacific Corporation5f425415-ed84-fc33-e063-6394a90a15f72026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 44C1TITANIUM DIOXIDEAmorepacific Corporation5f42d960-6b86-b4cd-e063-6294a90a98f32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45N1TITANIUM DIOXIDEAmorepacific Corporation5f4326fc-b3c3-1a8b-e063-6294a90a8d9b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45W1TITANIUM DIOXIDEAmorepacific Corporation5f4335c8-596f-3269-e063-6294a90a6c3d2026-11-01WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.